Who Brands - Brand Ownership DirectoryWho Brands
HomeBrowse BrandsCategoriesCompaniesCompareBlogQuizAbout
HomeBrowse BrandsCategoriesCompaniesCompareBlogQuizAbout
Who Brands

Your trusted reference for brand ownership information. We provide factual, comprehensive data about who owns the brands you know.

Stay in the know

Get the latest ownership updates delivered to your inbox.

Browse

  • All Brands
  • Categories
  • Companies
  • Countries
  • Compare Brands
  • Blog
  • Brand Quiz
  • RSS Feed

Company

  • About Us
  • Methodology
  • Contact
  • FAQ
  • Submit a Brand
  • List Your Brand
  • Write for Us

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Affiliate Disclosure
  • Disclaimer

Support Us

☕Buy me a coffee

2026 Who Brands. All information is provided for educational purposes. Brand names and logos are trademarks of their respective owners.

  1. Home
  2. Brands
  3. Healthcare & Pharmaceuticals
  4. Zocdoc
Zocdoc logo
Healthcare & Pharmaceuticals

Who Owns Zocdoc?

Zocdoc is owned by Zocdoc, Inc., a privately held healthcare technology company headquartered in New York City. Founded in 2007 by Cyrus Massoumi, Oliver Kharraz, and Nick Ganju, it operates a marketplace where patients find doctors and book appointments. The company has raised more than $300 million in funding, reached a peak valuation of $1.8 billion, and is led by CEO Oliver Kharraz. It is not publicly traded.

Parent Company

Zocdoc, Inc.

Founded

2007

Status

Private

Headquarters

New York, New York, USA

United StatesOfficial Website

Who Owns Zocdoc?

  • Parent Company: Zocdoc, Inc.
  • Ownership Type: Wholly owned
  • Company Type: Privately Held
BrandParent CompanyOwnership Type
ZocdocZocdoc, Inc.Wholly owned

Where to Buy

Disclosure: We may earn commission from purchases
AmazonZocdoc on Amazon

History of Zocdoc

  • Founded: 2007
  • Founders: Cyrus Massoumi, Oliver Kharraz, Nick Ganju

Zocdoc was founded in New York City in 2007 by Cyrus Massoumi, Oliver Kharraz, and Nick Ganju. Massoumi, a former McKinsey consultant, conceived the idea after a burst eardrum on a flight left him struggling to find a doctor who could see him quickly. The original product was a simple scheduling tool: patients could see doctors' real-time availability and book appointments online instead of calling offices.

The company raised $15 million in Series B funding in 2010 from Founders Fund and Khosla Ventures, capital it used to expand beyond New York. Its original business model charged doctors a flat subscription of roughly $3,000 per year to be listed and bookable on the platform.

Growth accelerated through the mid-2010s. By 2014 Zocdoc had five million monthly users, and a 2015 funding round valued the company at $1.8 billion. But the flat subscription model was breaking down: doctors paid the same fee whether they received one patient or a hundred, which worked in dense early markets but failed as the company expanded to areas where demand was thin. Kharraz has since described the strategy as nearly killing the company.

The board removed Massoumi as CEO in late 2015 and installed Kharraz the following day. Massoumi later sued the company alleging fraud, a case dismissed in 2024. Under Kharraz, Zocdoc spent years rebuilding its business model around per-booking fees of roughly $30 to $140 per new patient, a transition that met resistance from physicians, particularly in New York, its largest market, and involved years of face-to-face provider outreach.

The rebuilt model worked. Zocdoc became profitable, expanded to cover all 50 states, added telehealth during the COVID-19 pandemic, and processed appointment volumes typically fulfilled within 24 to 72 hours of booking. By 2025 the company employed roughly 800 to 1,300 people and was operating profitably without raising new equity capital since 2021.

About Zocdoc, Inc.

What is Zocdoc?

Zocdoc is a private healthcare technology company headquartered in New York City. It operates an online marketplace where patients find doctors, verify insurance, and book appointments, with providers paying per new-patient booking.

Who owns Zocdoc?

Zocdoc is owned by its private company Zocdoc, Inc. Ownership is held by founders, employees, and venture investors including Founders Fund and Khosla Ventures. There is no corporate parent.

Is Zocdoc a public company?

No. Zocdoc is privately held and has never listed publicly. It reached a peak valuation of $1.8 billion in 2015 and has not announced IPO plans.

When was Zocdoc founded?

Zocdoc was founded in 2007 in New York City by Cyrus Massoumi, Oliver Kharraz, and Nick Ganju.

How does Zocdoc make money?

Zocdoc charges healthcare providers roughly $30 to $140 for each new patient booking it delivers, plus fees for sponsored placement. Patients use the service free.

Is Zocdoc profitable?

Yes. Following its transition from flat subscriptions to per-booking pricing, Zocdoc reached profitability and has not raised equity capital since February 2021, funding operations from revenue and debt refinancing.

  • Founded: 2007
  • Headquarters: New York, New York, USA
  • Company Type: Privately Held
  • Revenue: not publicly disclosed (company is profitable)
  • Employees: Approximately 800 to 1,300

Visit Zocdoc, Inc. website

View full company profile for Zocdoc, Inc.

Where Is Zocdoc Made / Based?

  • Headquarters: New York, New York, USA

Zocdoc Categories & Tags

HealthcareAppointment BookingDigital HealthTelehealthMarketplace

Zocdoc Recalls & Controversies

Zocdoc's most significant controversy was internal. The 2015 board removal of co-founder and CEO Cyrus Massoumi produced years of litigation, with Massoumi alleging fraud and improper ouster. The case was dismissed in 2024, closing the dispute.

Externally, the per-booking pricing transition generated provider backlash, including complaints from New York physicians who argued the fees were burdensome, and some lawsuits arose during the rollout period. The company resolved these through extended implementation timelines and direct provider engagement rather than formal regulatory proceedings.

The platform has also faced periodic criticism over the accuracy of insurance coverage listings and provider directory information, a category-wide problem in healthcare directories subject to federal attention on "ghost network" directories. No major regulatory enforcement action against Zocdoc is on record.

Zocdoc Ownership: Pros & Cons

Advantages

  • +Founder-led governance with CEO Oliver Kharraz providing continuity
  • +Profitable operations reduce dependence on capital markets
  • +Independent neutrality lets it aggregate providers across competing health systems
  • +Per-booking model scales revenue with delivered patient volume
  • +$300+ million in historic funding built infrastructure competitors cannot easily replicate

Considerations

  • -Provider resistance to per-booking fees creates sales friction
  • -$1.8 billion peak valuation dates to 2015, and secondary market estimates have been lower
  • -Litigation history around the CEO transition reflects past governance instability
  • -Dependent on US healthcare structure in which provider directory data is often inaccurate
  • -Competition from integrated health system portals and insurer-owned channels

Frequently Asked Questions About Zocdoc

Sources & Further Reading

  • Zocdoc official site
  • Zocdoc company profile (PitchBook)
  • Zocdoc ownership profile (Brands Owned By)
  • Inc. profile on the pricing pivot
  • Zocdoc company data (TipRanks)

Competitors to Zocdoc

These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.

BrandParent CompanyCountryFoundedMarket PositionPrimary MarketGender Target
BetterHelpBetterHelp
Teladoc Health
United States
2013
Mass marketGlobalAll Genders

Learn More About Competitors

BetterHelpHealthcare Pharmaceuticals

BetterHelp

Owned by Teladoc Health, Inc.

World's largest online therapy platform, owned by Teladoc Health (NYSE: TDOC). Founded in 2013, connects users with a network of nearly 35,000 licensed clinicians via video, phone, and messaging.

online-therapymental-healthtelehealth

Competitive Analysis

Market Positioning: Zocdoc competes with 1 brands in the same categories, ranging from mass market to luxury positioning.

Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.

Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.

Independent Alternatives to Zocdoc

Looking for brands with different ownership structures? These similar brands are not owned by Zocdoc, Inc., giving you alternative choices that support different corporate structures.

AmgenHealthcare Pharmaceuticals

Amgen

Owned by Amgen Inc.

Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.

biotechnologypharmaceuticalsbiologics
Publicly Traded

Amgen operates independently without a large parent corporation.

GoodRxHealthcare Pharmaceuticals

GoodRx

Owned by GoodRx Holdings, Inc.

American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.

prescription-savingshealthcare-technologydrug-prices
Publicly Traded

GoodRx operates independently without a large parent corporation.

HCA HealthcareHealthcare Pharmaceuticals

HCA Healthcare

Owned by HCA Healthcare, Inc.

HCA Healthcare is the flagship brand of the largest U.S. for-profit hospital operator, a network of 190 hospitals and about 2,500 ambulatory sites across 19 states and England.

hospitalshealthcareemergency-care
Publicly Traded

HCA Healthcare operates independently without a large parent corporation.

PfizerHealthcare Pharmaceuticals

Pfizer

Owned by Pfizer Inc.

American multinational pharmaceutical corporation developing and manufacturing medicines, vaccines, and consumer healthcare products, one of the world's largest pharmaceutical companies.

pharmaceuticalvaccinesmedicines
Publicly Traded

Pfizer operates independently without a large parent corporation.

StrykerHealthcare Pharmaceuticals

Stryker

Owned by Stryker Corporation

Flagship medical technology brand of Stryker Corporation, founded in 1941 and a global leader in orthopaedic implants and surgical equipment.

medical-devicesorthopaedicssurgical-equipment
Publicly Traded

Stryker operates independently without a large parent corporation.

ADARxHealthcare Pharmaceuticals

ADARx

Owned by ADARx Pharmaceuticals, Inc.

Biotechnology brand of ADARx Pharmaceuticals, the San Diego siRNA company that listed on Nasdaq in September 2026.

biotechnologysirnapharmaceuticals
Publicly Traded

ADARx operates independently without a large parent corporation.

Jobs at Zocdoc, Inc.

Latest News About Zocdoc

Related Articles About Zocdoc

View more articles
Pfizer vs Johnson & Johnson: Pharma Brand Portfolios Compared
Brand Comparisons

Pfizer vs Johnson & Johnson: Pharma Brand Portfolios Compared

Pfizer and Johnson & Johnson are two of the most recognizable names in healthcare. But their brand portfolios look nothing alike. Here is a complete breakdown of what each company owns, how they got there, and what sets them apart.

Who Brands StaffMar 16, 2026
PharmaceuticalPfizerJohnson And Johnson
15 Pharmacy Brands and Their Corporate Parents
Brand Ownership

15 Pharmacy Brands and Their Corporate Parents

CVS spent $69 billion to buy Aetna. Walgreens acquired Boots for $15 billion. Amazon paid $1 billion for PillPack. Here are 15 pharmacy brands, who owns them, and how a once-diverse industry collapsed into two dominant players.

Who Brands StaffFeb 26, 2026
Pharmacy BrandsBrand OwnershipCvs
Who Owns Your Vitamins? The Hidden Corporate Parents Behind Supplement Brands
Brand Ownership

Who Owns Your Vitamins? The Hidden Corporate Parents Behind Supplement Brands

The supplement industry is worth $60+ billion but most brands are owned by pharma giants and food conglomerates. Here is who owns every major vitamin and supplement brand.

Who Brands StaffFeb 5, 2026
VitaminsSupplementsBrand Ownership
View more articles

People Also Searched

Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase
Brandpharmaceutical

Abbokinase

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Abrysvo
Brandrsv-vaccine

Abrysvo

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Accutane
Branddermatology

Accutane

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription
Browse All Healthcare & Pharmaceuticals

Last reviewed: October 1, 2026 · Reviewed by Who Brands Editorial Team